Template:Pediatric seizure DDX: Difference between revisions

Line 18: Line 18:
***[[Hydrocephalus]]
***[[Hydrocephalus]]
***[[Intracranial mass]]  
***[[Intracranial mass]]  
**[[Toxic ingestion]]
**Toxicologic
**Toxicologic
***[[Alcohol withdrawal]]
***[[Alcohol withdrawal]]
***[[Benzodiazepine withdrawal]]
***[[Benzodiazepine withdrawal]]
***[[Toxic ingestion]]
**Metabolic abnormalities: [[hyponatremia]], [[hypernatremia]], [[hypocalcemia]], [[hypomagnesemia]], [[hypoglycemia]], [[hyperglycemia]]
**Metabolic abnormalities: [[hyponatremia]], [[hypernatremia]], [[hypocalcemia]], [[hypomagnesemia]], [[hypoglycemia]], [[hyperglycemia]]
**Pyridoxine responsive seizure<ref>Baxter P. et al. Pyridoxine‐dependent and pyridoxine‐responsive seizures. Developmental Medicine & Child Neurology 2001, 43: 416–42</ref>
**Pyridoxine responsive seizure<ref>Baxter P. et al. Pyridoxine‐dependent and pyridoxine‐responsive seizures. Developmental Medicine & Child Neurology 2001, 43: 416–42</ref>

Revision as of 21:33, 11 March 2021

Pediatric seizure

  1. Baxter P. et al. Pyridoxine‐dependent and pyridoxine‐responsive seizures. Developmental Medicine & Child Neurology 2001, 43: 416–42